Milan Vrabel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Milan Vrabel has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Rastislav Dzijak
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16000, Prague, Czech Republic
21 shared publications - Martin Dračínský
Czech Academy of Sciences Flemingovo nám. 2
16 shared publications - Thomas Carell
Ludwig-Maximilians-Universität München
15 shared publications - Radek Pohl
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
11 shared publications - Juraj Galeta
Institute of Organic Chemistry and Biochemistry of the CAS Flemingovo nám. 2 16000 Prague Czech Republic
10 shared publications - Hannes Mikula
TU Wien
9 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Chemistry – A European Journal
- p. e71703
Development of Blue‐to‐Near‐Infrared rTCO–Caged Fluorogenic Probes for Click‐to‐Release Monitoring
Bioorthogonal click‐to‐release reactions provide a powerful strategy for chemically controlled activation of functional molecules in biological systems. Here, we report the development of a series of 12 trans ‐cyclooctene‐caged fluorogenic probes, including 11 new compounds, covering the blue‐to‐near‐infrared spectral region. Using different probe designs, including direct caging, self‐immolative linkers, and covalent assembly, we evaluated their fluorescence turn‐on, release kinetics, and performance in live cells upon activation with a sulfonated tetrazine trigger. The best‐performing probes exhibited a 44‐fold fluorescence turn‐on and a second‐order rate constant of 1027 M − 1 s − 1 , while selected probes produced detectable intracellular fluorescence within 2 min and reached signal saturation within approximately 10 min. The results reveal important differences in probe behavior between solution and cells, highlighting the need to evaluate fluorogenic click‐to‐release probes in their intended biological context. This study expands the available toolbox for monitoring tetrazine‐triggered bioorthogonal release reactions and identifies promising candidates for cellular applications.
- 21 September 2026
- Published by Wiley in Chemistry – A European Journal
- p. e71703
Open AccessDevelopment of Blue‐to‐Near‐Infrared rTCO–Caged Fluorogenic Probes for Click‐to‐Release Monitoring
Bioorthogonal click‐to‐release reactions provide a powerful strategy for chemically controlled activation of functional molecules in biological systems. Here, we report the development of a series of 12 trans ‐cyclooctene‐caged fluorogenic probes, including 11 new compounds, covering the blue‐to‐near‐infrared spectral region. Using different probe designs, including direct caging, self‐immolative linkers, and covalent assembly, we evaluated their fluorescence turn‐on, release kinetics, and performance in live cells upon activation with a sulfonated tetrazine trigger. The best‐performing probes exhibited a 44‐fold fluorescence turn‐on and a second‐order rate constant of 1027 M − 1 s − 1 , while selected probes produced detectable intracellular fluorescence within 2 min and reached signal saturation within approximately 10 min. The results reveal important differences in probe behavior between solution and cells, highlighting the need to evaluate fluorogenic click‐to‐release probes in their intended biological context. This study expands the available toolbox for monitoring tetrazine‐triggered bioorthogonal release reactions and identifies promising candidates for cellular applications.
- Open Access
- 26 August 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Electrostatic attraction unlocks rapid tetrazine– trans-cyclooctene click chemistry in organic solvents
The inverse electron-demand Diels–Alder (IEDDA) reaction between tetrazines (Tz) and trans -cyclooctenes (TCO) is among the fastest click reactions known. Although extensively optimized for aqueous environments, its reactivity in organic solvents remains strongly constrained, limiting applications under non-aqueous conditions. Here we report a charge-mediated strategy that enables rapid tetrazine– trans -cyclooctene ligation in organic media through electrostatic attraction. Reversible association between complementary charged Tz and TCO affords apparent second-order rate values of up to 10 7 M -1 s -1 in organic solvents, exceeding typical non-aqueous IEDDA rates by several orders of magnitude and approaching the fastest tetrazine ligations reported in water. Mechanistic studies support a reversible ion-pairing model, in which electrostatic pre-association generates unusual concentration-dependent kinetics, while preserving high reactivity even at nanomolar levels. We demonstrate the practical utility of this rate enhancement through selective peptide ligation and rapid tetrazine ligation of water-insoluble substrates. These findings establish intermolecular electrostatic attraction as an orthogonal framework for controlling IEDDA kinetics beyond conventional reagent-centered optimization.
- 26 August 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessElectrostatic attraction unlocks rapid tetrazine– trans-cyclooctene click chemistry in organic solvents
The inverse electron-demand Diels–Alder (IEDDA) reaction between tetrazines (Tz) and trans -cyclooctenes (TCO) is among the fastest click reactions known. Although extensively optimized for aqueous environments, its reactivity in organic solvents remains strongly constrained, limiting applications under non-aqueous conditions. Here we report a charge-mediated strategy that enables rapid tetrazine– trans -cyclooctene ligation in organic media through electrostatic attraction. Reversible association between complementary charged Tz and TCO affords apparent second-order rate values of up to 10 7 M -1 s -1 in organic solvents, exceeding typical non-aqueous IEDDA rates by several orders of magnitude and approaching the fastest tetrazine ligations reported in water. Mechanistic studies support a reversible ion-pairing model, in which electrostatic pre-association generates unusual concentration-dependent kinetics, while preserving high reactivity even at nanomolar levels. We demonstrate the practical utility of this rate enhancement through selective peptide ligation and rapid tetrazine ligation of water-insoluble substrates. These findings establish intermolecular electrostatic attraction as an orthogonal framework for controlling IEDDA kinetics beyond conventional reagent-centered optimization.
- Open Access
- 1 June 2026
- Published by Wiley in Chemistry – A European Journal
- Vol. 32 (35) , e71198
Organelle‐Resolved Tetrazine‐ trans ‐Cyclooctene Click Chemistry for Cargo Delivery and Release
Accurate delivery of small molecules to specific cell compartments or organelles offers great potential for bioimaging and targeted therapy but remains challenging to predict and control. In this study, we evaluate a modular strategy for organelle‐directed delivery based on organelle‐targeting groups combined with tetrazine‐ trans ‐cyclooctene bioorthogonal chemistry. We demonstrate that organelle‐targeting probes bearing tetrazine or trans ‐cyclooctene can efficiently undergo inverse‐electron‐demand Diels‐Alder reactions within various cellular compartments, including the plasma membrane, mitochondria, nucleus, endoplasmic reticulum, and lysosomes. Using this method, we localize fluorophores and the cytotoxic drug doxorubicin to specific organelles in living cells. We further show that tetrazine‐ or trans ‐cyclooctene‐modified doxorubicin prodrugs restore cytotoxic activity upon click‐to‐release activation inside cells. However, direct comparisons of different probe architectures revealed that organelle targeting and reaction efficiency are highly sensitive to structural context, cargo type, and subcellular environment, and cannot be predicted solely from targeting motifs. Overall, these findings establish a framework for comparing organelle‐targeted bioorthogonal chemistry and offer practical guidance for designing probes and prodrugs that enable precise spatiotemporal control of small‐molecule activity in living cells.
- 1 June 2026
- Published by Wiley in Chemistry – A European Journal
- Vol. 32 (35) , e71198
Open AccessOrganelle‐Resolved Tetrazine‐ trans ‐Cyclooctene Click Chemistry for Cargo Delivery and Release
Accurate delivery of small molecules to specific cell compartments or organelles offers great potential for bioimaging and targeted therapy but remains challenging to predict and control. In this study, we evaluate a modular strategy for organelle‐directed delivery based on organelle‐targeting groups combined with tetrazine‐ trans ‐cyclooctene bioorthogonal chemistry. We demonstrate that organelle‐targeting probes bearing tetrazine or trans ‐cyclooctene can efficiently undergo inverse‐electron‐demand Diels‐Alder reactions within various cellular compartments, including the plasma membrane, mitochondria, nucleus, endoplasmic reticulum, and lysosomes. Using this method, we localize fluorophores and the cytotoxic drug doxorubicin to specific organelles in living cells. We further show that tetrazine‐ or trans ‐cyclooctene‐modified doxorubicin prodrugs restore cytotoxic activity upon click‐to‐release activation inside cells. However, direct comparisons of different probe architectures revealed that organelle targeting and reaction efficiency are highly sensitive to structural context, cargo type, and subcellular environment, and cannot be predicted solely from targeting motifs. Overall, these findings establish a framework for comparing organelle‐targeted bioorthogonal chemistry and offer practical guidance for designing probes and prodrugs that enable precise spatiotemporal control of small‐molecule activity in living cells.
- Open Access
ChemCell: Chemical Tethering of Large Biomolecules to Cell Surfaces through Diels-Alder Ligation
Chemical engineering of cellular surfaces offers a powerful tool to endow cells with new properties and functions, yet methods for adding complex biomolecules to cell membranes remain underdeveloped. While technologies for targeted degradation of cell surface components are advancing, few approaches exist that allow efficient attachment of large biomolecules. To address this, we introduce ChemCell technology—a platform for non-genetic surface engineering of cells via metabolic installation of trans-cyclooctene (TCO) groups. These TCO groups undergo rapid and selective reactions with tetrazine-modified biomolecules, enabling the efficient tethering of diverse functional groups. This method allows for the precise attachment of proteins, peptides, enzymes, oligonucleotides, therapeutic antibodies, and large protein complexes to cell surfaces, expanding the toolbox for cellular modification and offering new possibilities for cell-based therapies and diagnostics.
Open AccessChemCell: Chemical Tethering of Large Biomolecules to Cell Surfaces through Diels-Alder Ligation
Chemical engineering of cellular surfaces offers a powerful tool to endow cells with new properties and functions, yet methods for adding complex biomolecules to cell membranes remain underdeveloped. While technologies for targeted degradation of cell surface components are advancing, few approaches exist that allow efficient attachment of large biomolecules. To address this, we introduce ChemCell technology—a platform for non-genetic surface engineering of cells via metabolic installation of trans-cyclooctene (TCO) groups. These TCO groups undergo rapid and selective reactions with tetrazine-modified biomolecules, enabling the efficient tethering of diverse functional groups. This method allows for the precise attachment of proteins, peptides, enzymes, oligonucleotides, therapeutic antibodies, and large protein complexes to cell surfaces, expanding the toolbox for cellular modification and offering new possibilities for cell-based therapies and diagnostics.
- Open Access
- 5 March 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (16) , e24223
Small‐Molecule Activation of mRNA Translation by Click‐to‐Release Reaction in Cells
MRNA is an emerging medical modality, however, approaches to control its activity lack behind other biologics. Bioorthogonal click‐to‐release reactions enable breaking chemical bonds at high reaction rates even in living cells to release a functionally active biomolecule (“uncaging”). We developed a 5′ cap modified with a trans ‐cyclooctene (TCO‐cap) that reacts with hydroxyaryl‐tetrazines to efficiently release the native cap 0. This strategy is compatible with in vitro transcription and facilitates HPLC‐based purification of the resulting TCO‐capped mRNA, circumventing the need to digest uncapped mRNA produced in the process. Using eGFP‐ and luciferase‐mRNAs in mammalian cells, we show that TCO‐capped mRNAs are translationally muted and can be activated for translation by addition of cell‐permeable, non‐toxic sulfonamide‐modified hydroxyphenyl‐tetrazines. This work presents a new approach for small‐molecule‐induced translation in eukaryotes with potential to be applicable to any mRNA.
- 5 March 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (16) , e24223
Open AccessSmall‐Molecule Activation of mRNA Translation by Click‐to‐Release Reaction in Cells
MRNA is an emerging medical modality, however, approaches to control its activity lack behind other biologics. Bioorthogonal click‐to‐release reactions enable breaking chemical bonds at high reaction rates even in living cells to release a functionally active biomolecule (“uncaging”). We developed a 5′ cap modified with a trans ‐cyclooctene (TCO‐cap) that reacts with hydroxyaryl‐tetrazines to efficiently release the native cap 0. This strategy is compatible with in vitro transcription and facilitates HPLC‐based purification of the resulting TCO‐capped mRNA, circumventing the need to digest uncapped mRNA produced in the process. Using eGFP‐ and luciferase‐mRNAs in mammalian cells, we show that TCO‐capped mRNAs are translationally muted and can be activated for translation by addition of cell‐permeable, non‐toxic sulfonamide‐modified hydroxyphenyl‐tetrazines. This work presents a new approach for small‐molecule‐induced translation in eukaryotes with potential to be applicable to any mRNA.
- Open Access
- 1 March 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (16) , e24223
Small‐Molecule Activation of mRNA Translation by Click‐to‐Release Reaction in Cells
MRNA is an emerging medical modality, however, approaches to control its activity lack behind other biologics. Bioorthogonal click‐to‐release reactions enable breaking chemical bonds at high reaction rates even in living cells to release a functionally active biomolecule (“uncaging”). We developed a 5′ cap modified with a trans ‐cyclooctene (TCO‐cap) that reacts with hydroxyaryl‐tetrazines to efficiently release the native cap 0. This strategy is compatible with in vitro transcription and facilitates HPLC‐based purification of the resulting TCO‐capped mRNA, circumventing the need to digest uncapped mRNA produced in the process. Using eGFP‐ and luciferase‐mRNAs in mammalian cells, we show that TCO‐capped mRNAs are translationally muted and can be activated for translation by addition of cell‐permeable, non‐toxic sulfonamide‐modified hydroxyphenyl‐tetrazines. This work presents a new approach for small‐molecule‐induced translation in eukaryotes with potential to be applicable to any mRNA.
- 1 March 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (16) , e24223
Open AccessSmall‐Molecule Activation of mRNA Translation by Click‐to‐Release Reaction in Cells
MRNA is an emerging medical modality, however, approaches to control its activity lack behind other biologics. Bioorthogonal click‐to‐release reactions enable breaking chemical bonds at high reaction rates even in living cells to release a functionally active biomolecule (“uncaging”). We developed a 5′ cap modified with a trans ‐cyclooctene (TCO‐cap) that reacts with hydroxyaryl‐tetrazines to efficiently release the native cap 0. This strategy is compatible with in vitro transcription and facilitates HPLC‐based purification of the resulting TCO‐capped mRNA, circumventing the need to digest uncapped mRNA produced in the process. Using eGFP‐ and luciferase‐mRNAs in mammalian cells, we show that TCO‐capped mRNAs are translationally muted and can be activated for translation by addition of cell‐permeable, non‐toxic sulfonamide‐modified hydroxyphenyl‐tetrazines. This work presents a new approach for small‐molecule‐induced translation in eukaryotes with potential to be applicable to any mRNA.
- Open Access
- 28 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (1) , 1183-1196
Fluorescence Quenching Properties and Bioimaging Applications of Readily Accessible Blue to Far-Red Fluorogenic Triazinium Salts
Fluorogenic probes, which become fluorescent only upon specific activation, enable no-wash imaging with an excellent signal-to-noise ratio. Despite significant progress in the development of such probes, challenges remain in achieving efficient quenching and substantial fluorescence enhancement across the whole visible spectrum while maintaining good synthetic accessibility. In this work, we introduce a new class of bioorthogonally activatable fluorogenic probes based on triazinium salts (Trz+), which act as highly efficient fluorescence quenchers. These Trz+-fluorophore conjugates are easily synthesized from common precursors and commercially available fluorophores, covering a broad spectral range from blue to far-red wavelengths. Mechanistic studies provide molecular insights into the quenching mechanism, attributed to the charged Trz+ core, which triggers substantial fluorescence turn-on upon bioorthogonal reaction with a strained dienophile. The versatility and ease of synthesis of these probes, along with their noteworthy photophysical properties, make them highly valuable for a wide range of bioimaging applications, including the visualization of intracellular organelles, drug molecules, HaloTag fusion proteins, genetically encoded intra- and extracellular proteins, cell surface antigens, and metabolically labeled glycoconjugates.
- 28 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (1) , 1183-1196
Open AccessFluorescence Quenching Properties and Bioimaging Applications of Readily Accessible Blue to Far-Red Fluorogenic Triazinium Salts
Fluorogenic probes, which become fluorescent only upon specific activation, enable no-wash imaging with an excellent signal-to-noise ratio. Despite significant progress in the development of such probes, challenges remain in achieving efficient quenching and substantial fluorescence enhancement across the whole visible spectrum while maintaining good synthetic accessibility. In this work, we introduce a new class of bioorthogonally activatable fluorogenic probes based on triazinium salts (Trz+), which act as highly efficient fluorescence quenchers. These Trz+-fluorophore conjugates are easily synthesized from common precursors and commercially available fluorophores, covering a broad spectral range from blue to far-red wavelengths. Mechanistic studies provide molecular insights into the quenching mechanism, attributed to the charged Trz+ core, which triggers substantial fluorescence turn-on upon bioorthogonal reaction with a strained dienophile. The versatility and ease of synthesis of these probes, along with their noteworthy photophysical properties, make them highly valuable for a wide range of bioimaging applications, including the visualization of intracellular organelles, drug molecules, HaloTag fusion proteins, genetically encoded intra- and extracellular proteins, cell surface antigens, and metabolically labeled glycoconjugates.
- 8 May 2025
- Published by Georg Thieme Verlag KG
2 From Biological Chemistry to Bioorthogonal Reactions
This contribution aims to trace the origins of bioorthogonal chemistry, from its roots in early alchemy and the Scientific Revolution, to its development as a response to the quest to understand the fundamental principles of life. The development and application of chemical tools to study and manipulate biological processes and biomolecules laid the foundation for modern chemical biology. With the advent of the first chemical reactions that proceed selectively and efficiently without interfering with biological systems, scientists gained a unique set of tools to achieve an unprecedented level of understanding of biological processes at the molecular level. New techniques such as strain-promoted azide–alkyne cycloaddition (SPAAC), tetrazine ligation, and artificial metalloenzymes have further advanced the field. These modern tools of chemistry have significantly extended the potential of bioorthogonal chemistry and hold the promise of revolutionizing healthcare through improved drug delivery and advanced diagnostic tools. By placing these achievements in the context of the history of science, it is clear that this field has a bright future. As our understanding of bioorthogonal reactions deepens and technology evolves, we can anticipate their incorporation into a wide range of practices, potentially ushering in a new era of advanced personalized treatments.
- 8 May 2025
- Published by Georg Thieme Verlag KG
2 From Biological Chemistry to Bioorthogonal Reactions
This contribution aims to trace the origins of bioorthogonal chemistry, from its roots in early alchemy and the Scientific Revolution, to its development as a response to the quest to understand the fundamental principles of life. The development and application of chemical tools to study and manipulate biological processes and biomolecules laid the foundation for modern chemical biology. With the advent of the first chemical reactions that proceed selectively and efficiently without interfering with biological systems, scientists gained a unique set of tools to achieve an unprecedented level of understanding of biological processes at the molecular level. New techniques such as strain-promoted azide–alkyne cycloaddition (SPAAC), tetrazine ligation, and artificial metalloenzymes have further advanced the field. These modern tools of chemistry have significantly extended the potential of bioorthogonal chemistry and hold the promise of revolutionizing healthcare through improved drug delivery and advanced diagnostic tools. By placing these achievements in the context of the history of science, it is clear that this field has a bright future. As our understanding of bioorthogonal reactions deepens and technology evolves, we can anticipate their incorporation into a wide range of practices, potentially ushering in a new era of advanced personalized treatments.
- Open Access
- 10 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Fluorescence Quenching Properties and Bioimaging Applications of Readily Accessible Blue to Far-Red Fluorogenic Triazinium Salts
Fluorogenic probes, which become fluorescent only upon specific activation, enable no-wash imaging with an excel-lent signal-to-noise ratio. Despite significant progress in the development of such probes, challenges remain in achiev-ing efficient quenching and substantial fluorescence enhancement across the whole visible spectrum while maintain-ing good synthetic accessibility. In this work, we introduce a new class of bioorthogonally activatable fluorogenic probes based on triazinium salts (Trz+), which act as highly efficient fluorescence quenchers. These Trz+-fluorophore conjugates are easily synthesized from common precursors and commercially available fluorophores, covering a broad spectral range from blue to far-red wavelengths. Computational studies provide molecular insights into the unique combined quenching mechanism, attributed to the charged Trz+ core, which triggers substantial fluorescence turn-on upon bioorthogonal reaction with a strained dienophile. The versatility and ease of synthesis of these probes, along with their noteworthy photophysical properties, make them highly valuable for a wide range of bioimaging applica-tions, including the visualization of intracellular organelles, drug molecules, HaloTag fusion proteins, genetically en-coded intra- and extracellular proteins, cell surface antigens, and metabolically labeled glycoconjugates.
- 10 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFluorescence Quenching Properties and Bioimaging Applications of Readily Accessible Blue to Far-Red Fluorogenic Triazinium Salts
Fluorogenic probes, which become fluorescent only upon specific activation, enable no-wash imaging with an excel-lent signal-to-noise ratio. Despite significant progress in the development of such probes, challenges remain in achiev-ing efficient quenching and substantial fluorescence enhancement across the whole visible spectrum while maintain-ing good synthetic accessibility. In this work, we introduce a new class of bioorthogonally activatable fluorogenic probes based on triazinium salts (Trz+), which act as highly efficient fluorescence quenchers. These Trz+-fluorophore conjugates are easily synthesized from common precursors and commercially available fluorophores, covering a broad spectral range from blue to far-red wavelengths. Computational studies provide molecular insights into the unique combined quenching mechanism, attributed to the charged Trz+ core, which triggers substantial fluorescence turn-on upon bioorthogonal reaction with a strained dienophile. The versatility and ease of synthesis of these probes, along with their noteworthy photophysical properties, make them highly valuable for a wide range of bioimaging applica-tions, including the visualization of intracellular organelles, drug molecules, HaloTag fusion proteins, genetically en-coded intra- and extracellular proteins, cell surface antigens, and metabolically labeled glycoconjugates.
- 8 December 2024
- Published by Wiley in Angewandte Chemie
- Vol. 137 (5)
Titelbild: Hydroxylierte Aryl‐Tetrazine als bioorthogonale Scheren zur systematischen Spaltung von trans‐Cyclooctenen (Angew. Chem. 5/2025)
- 8 December 2024
- Published by Wiley in Angewandte Chemie
- Vol. 137 (5)
Titelbild: Hydroxylierte Aryl‐Tetrazine als bioorthogonale Scheren zur systematischen Spaltung von trans‐Cyclooctenen (Angew. Chem. 5/2025)